MiMedx Group, Inc.
MDXG
$4.27
$0.071.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -34.73% | -33.12% | 27.11% | 35.30% | 13.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.73% | -33.12% | 27.11% | 35.30% | 13.07% |
| Cost of Revenue | 6.96% | 4.89% | 12.69% | 22.17% | 25.76% |
| Gross Profit | -44.47% | -41.91% | 30.32% | 38.22% | 10.47% |
| SG&A Expenses | -6.82% | -11.24% | 19.62% | 27.39% | 40.37% |
| Depreciation & Amortization | 191.00% | 204.04% | -33.16% | -41.67% | -47.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.95% | -6.15% | 18.66% | 26.09% | 35.26% |
| Operating Income | -249.28% | -294.51% | 89.07% | 93.63% | -47.25% |
| Income Before Tax | -236.70% | -278.02% | 93.75% | 100.10% | -43.97% |
| Income Tax Expenses | -186.75% | -381.37% | 73.29% | 72.30% | -39.43% |
| Earnings from Continuing Operations | -254.29% | -254.63% | 104.24% | 112.59% | -45.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -254.29% | -254.63% | 104.24% | 106.89% | -45.43% |
| EBIT | -249.28% | -294.51% | 89.07% | 93.63% | -47.25% |
| EBITDA | -208.99% | -226.00% | 71.86% | 117.84% | -36.78% |
| EPS Basic | -254.22% | -253.46% | 102.77% | 105.26% | -45.57% |
| Normalized Basic EPS | -236.73% | -276.71% | 90.87% | 93.78% | -44.16% |
| EPS Diluted | -267.33% | -253.46% | 99.40% | 113.59% | -49.83% |
| Normalized Diluted EPS | -238.24% | -279.17% | 90.95% | 93.12% | -44.15% |
| Average Basic Shares Outstanding | 0.02% | 0.80% | 0.74% | 0.73% | 0.30% |
| Average Diluted Shares Outstanding | -1.02% | -0.82% | 0.63% | 0.90% | 0.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |